跳到主要导航
跳到搜索
跳到主要内容
北京理工大学 首页
English
中文
首页
师资队伍
研究单位
科研成果
奖项
按专业知识、名称或附属进行搜索
查看 Scopus 资料
董 磊
生命学院
h-index
1186
引用
16
H-指数
根据储存在 Pure 的刊物以及来自 Scopus 的引用文献数量计算
2014
2024
每年的科研成果
概览
指纹图谱
合作网络
科研成果
(41)
指纹图谱
深入其中 Lei Dong 为活跃的研究主题。这些主题标签来自此人的成果。它们共同形成唯一的指纹。
分类
加权
按字母排序
Pharmacology, Toxicology and Pharmaceutical Science
Acute Kidney Failure
42%
Beta Chemokine
7%
Brain Tumor
14%
Breast Cancer
42%
Caspase 3
10%
Cell Cycle
10%
Cell Proliferation
10%
Chemokine Receptor
42%
Colon Cancer
21%
Cyclin A
21%
Drug Resistance
14%
Epidermal Growth Factor Receptor
10%
Gamma Chemokine
42%
Gelatinase A
10%
Glioblastoma
42%
Glioma
42%
Hepatitis
12%
Inflammasome
42%
Juvenile Myelomonocytic Leukemia
14%
Leukemia
42%
Ligase Inhibitor
10%
Mammalian Target of Rapamycin
42%
Myeloproliferative Neoplasm
42%
Nasopharynx Carcinoma
42%
Neoplasm
100%
Nephritis
42%
Non Receptor Protein Tyrosine Phosphatase 2
42%
Noonan Syndrome
21%
Nucleotide Binding Oligomerization Domain Like Receptor
12%
Oncolytic Virus
8%
Phosphatase
17%
Phosphatidylinositol 3 Kinase
42%
Plerixafor
42%
Protein Kinase B
42%
Protein P53
27%
Protein Tyrosine Kinase Inhibitor
10%
Protein Tyrosine Phosphatase
42%
Protein Tyrosine Phosphatase 1B
42%
Protocatechualdehyde
42%
Renal Cell Carcinoma
21%
Temozolomide
42%
Tensin
17%
Therapeutic Use
21%
Tumor Promoter
21%
Tumor Suppressor Protein
51%
Ubiquitin Protein Ligase
10%
Ubiquitin Protein Ligase E3
21%
Uvea Melanoma
42%
Vasculotropin Receptor 1
42%
Virotherapy
42%
Biochemistry, Genetics and Molecular Biology
Aggresome
42%
Allosteric Regulation
42%
Autoinhibition
21%
C2 Domain
21%
Calcineurin
42%
Calcineurin
12%
CCL3
42%
Cell Heterogeneity
21%
Chemosensitivity
42%
Chromatin Immunoprecipitation
28%
Circular RNA
42%
Clinical Study
10%
Cyclin A
21%
Endoplasmic Reticulum Stress
42%
Gain of Function Mutation
42%
Gene Mutation
42%
Gene Signature
42%
Genomic Structure
14%
Germline
14%
Germline Mutation
21%
HECT Domain
21%
Immune Privilege
10%
Immunogenicity
10%
Independent Pathway
14%
Interleukin-1
14%
KEAP1
42%
Mammalian Target of Rapamycin Complex 2
42%
MAPK/ERK Pathway
21%
Mir-184
42%
NBR1
14%
Phosphatase
42%
PI3K/AKT/mTOR Pathway
14%
Progeny
14%
Protein Tyrosine Phosphatase
28%
PTPN11
42%
Quantitative Reverse Transcription Polymerase Chain Reaction
14%
Receptor Antagonist
14%
Significance Analysis of Microarrays
14%
Single Nucleotide Polymorphism
28%
Somatic Mutation
21%
Tensin
42%
Transcription Factor Nrf2
42%
Tumor Suppressor Gene
21%
Tyrosine Kinase Inhibitor
14%
Ubiquitin Ligase
17%
Ubiquitination
42%
Unfolded Protein Response
26%
Virus Recombinant
42%
Wild Type
42%
WW Domain
21%
Medicine and Dentistry
Akt/mTOR Signaling
42%
Beta Chemokine
7%
Bone Marrow Cell
7%
Bone Marrow Microenvironment
7%
C2 Domain
21%
Chemokine Receptor
42%
Chronic Liver Disease
42%
Colony Formation
8%
Gain of Function Mutation
42%
Gamma Chemokine
42%
Gelatinase A
14%
Germline Mutation
21%
Glioblastoma
42%
Glioblastoma Cell Line
14%
Hepatitis
12%
Hepatitis Virus
6%
Inflammasome
12%
Inflammatory Cytokine
7%
Interleukin 18
6%
Juvenile Myelomonocytic Leukemia
42%
Leukemogenesis
7%
Macrophage Inflammatory Protein 1alpha
7%
Mammalian Target of Rapamycin Complex 2
21%
Mammalian Target of Rapamycin Inhibitor
26%
MCF-7 Cell Line
14%
Mechanistic Target of Rapamycin
10%
Mitofusin 2
42%
Multidrug Resistance
9%
Multiprotein Complex
6%
Myeloproliferative Neoplasm
28%
NLRP3 Inflammasome
42%
Nonalcoholic Fatty Liver
6%
Noonan Syndrome
21%
Nucleotide Binding Oligomerization Domain Like Receptor
12%
Osteoblast
7%
Osteoprogenitor Cell
7%
Phosphoinositide 3-Kinase
42%
Protein Tyrosine Phosphatase SHP 2
7%
Pyrin Domain
6%
Receptor Antagonist
7%
Receptor Family
6%
Somatic Mutation
21%
Stem Cell
7%
Tumor Promoter
21%
Tumor Suppressor Protein
21%
U87
9%
Ubiquitin Protein Ligase E3
21%
Ubiquitination
21%
Uveal Melanoma
42%
WW Domain
21%
